Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO4917523 in Adult Patients With Fragile X Syndrome
NCT01015430Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2009
- Primary completion
- Jan 2011
- Countries
- 1
01
Overview
A Phase 2 trial of basimglurant in Fragile X syndrome (FXS), sponsored by Roche. Started Nov 2009; status: completed.
02
Drugs
basimglurant
03
Conditions
Fragile X syndrome (FXS)
Beyond the preview
Go deeper on NCT01015430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01015430.